+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Topical Hemostat Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Topical Hemostat Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Topical Hemostat Market by Product Type, Application, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989882
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In a complex healthcare environment where surgical safety and clinical efficiency are paramount, the topical hemostat market has established itself as a cornerstone for elevating patient outcomes and optimizing procedural workflows. With evolving clinical standards and intensified regulatory scrutiny, understanding this market is critical for executive decision-makers seeking continued growth and resilience.

Market Snapshot: Topical Hemostat Market Growth Dynamics

The topical hemostat market grew from USD 2.26 billion in 2024 to USD 2.41 billion in 2025. Forecasts indicate continued expansion at a CAGR of 6.85%, with the market projected to reach USD 3.36 billion by 2030. Growth is supported by ongoing innovation in advanced biomaterials, minimally invasive surgical techniques, and increased adoption within high-volume healthcare systems. Integration of digital health and robotics into surgical practice furthers demand for reliable hemostatic agents that meet diverse procedural needs.

Scope & Segmentation

  • Product Types: Collagen, cyanoacrylate, gelatin, oxidized regenerated cellulose (fabric and powder forms), thrombin
  • Applications: Cardiovascular surgery (bypass, valve), dental surgery (extraction, restorative), general surgery (laparoscopic, open), neurosurgery (adult, pediatric), orthopedic surgery (joint replacement, spine)
  • End Users: Ambulatory surgery centers (multi-specialty, orthopedic), clinics (dental, dermatology), hospitals (private, public), specialty centers (cardiac, neurology)
  • Distribution Channels: Direct sales (field sales, tele-sales), local distributors, national distributors, hospital pharmacies (inpatient, outpatient), online (institutional websites, third-party marketplaces)
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (selected countries), Asia-Pacific (including China, India, Japan, Australia, others)
  • Technologies: Bioengineered collagen matrices, next-generation cyanoacrylate, novel gelatin-thrombin combinations, integrated digital analytics, smart polymers
  • Leading Companies: Johnson & Johnson, Baxter International Inc., B. Braun Melsungen AG, Medtronic plc, 3M Company, Takeda Pharmaceutical Company Limited, Grifols S.A., CryoLife Inc., Integra LifeSciences Holdings Corporation, Terumo Corporation

Key Takeaways for Senior Decision-Makers

  • Bioengineered and peptide-enhanced hemostats are rapidly influencing product portfolios, supporting both generalist and specialty procedural demands.
  • Strategic alliances between manufacturers and software developers are increasing procedural accuracy and shortening operative times through real-time imaging integration.
  • Regional preferences and clinical protocols strongly affect adoption, with high uptake in hospital-dense markets and increasing demand in expanding or modernizing healthcare infrastructures.
  • Group purchasing organizations and direct supply chain models are enhancing price transparency and encouraging the adoption of cost-efficient delivery technologies.
  • Competitive advantage is shifting toward companies that invest in modular delivery platforms and digital tracking to ensure supply chain integrity and adaptability.
  • Ongoing regulatory evolution is creating opportunities for early access programs, while specialty centers seek agents with rapid onset and minimal tissue reactions for complex procedures.

Tariff Impact on Market Structure

Recent tariffs introduced in the United States have altered the cost landscape for both raw materials and finished medical products in this sector. Companies reliant on imported collagen and cellulose have responded by renegotiating supplier contracts and pursuing local sourcing strategies, which has increased supply chain complexity but spurred exploration of alternative substrates. Health providers are leaning into group purchasing and direct procurement to offset price increases, with some specialty centers moving toward direct-to-manufacturer models. These adaptations are accelerating uptake of cost-containment technologies and promoting pricing transparency throughout the supply chain.

Methodology & Data Sources

This report utilizes a mixed-methods approach, leveraging primary interviews with key clinicians, procurement professionals, and R&D leaders. Rigorous secondary analysis draws from peer-reviewed publications, regulatory filings, commercial databases, and public financial materials. Market segment validation through triangulation ensures robust and actionable insights, while trade impact is measured using customs and tariff data.

Why This Report Matters

  • Enables strategic investment by pinpointing high-growth segments and emerging technology trends within the topical hemostat industry.
  • Equips leadership with actionable intelligence on competitive positioning, regulatory shifts, and supply chain innovations across key geographies.

Conclusion

The topical hemostat market confronts evolving clinical, regulatory, and global trade dynamics. Proactive adaptation to technology, sourcing, and procurement strategies will be essential for stakeholders aiming to realize long-term operational and clinical value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Topical Hemostat Market, by Product Type
8.1. Introduction
8.2. Collagen
8.3. Cyanoacrylate
8.4. Gelatin
8.5. Oxidized Regenerated Cellulose
8.5.1. Fabric
8.5.2. Powder
8.6. Thrombin
9. Topical Hemostat Market, by Application
9.1. Introduction
9.2. Cardiovascular Surgery
9.2.1. Bypass
9.2.2. Valve
9.3. Dental Surgery
9.3.1. Extraction
9.3.2. Restorative
9.4. General Surgery
9.4.1. Laparoscopic
9.4.2. Open
9.5. Neurosurgery
9.5.1. Adult
9.5.2. Pediatric
9.6. Orthopedic Surgery
9.6.1. Joint Replacement
9.6.2. Spine
10. Topical Hemostat Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Centers
10.2.1. Multi-Specialty
10.2.2. Orthopedic
10.3. Clinics
10.3.1. Dental
10.3.2. Dermatology
10.4. Hospitals
10.4.1. Private
10.4.2. Public
10.5. Specialty Centers
10.5.1. Cardiac
10.5.2. Neurology
11. Topical Hemostat Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.2.1. Field Sales
11.2.2. Tele-Sales
11.3. Distributors
11.3.1. Local Distributors
11.3.2. National Distributors
11.4. Hospital Pharmacies
11.4.1. Inpatient Pharmacies
11.4.2. Outpatient Pharmacies
11.5. Online
11.5.1. Institutional Websites
11.5.2. Third Party Marketplaces
12. Americas Topical Hemostat Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Topical Hemostat Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Topical Hemostat Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Johnson & Johnson
15.3.2. Baxter International Inc.
15.3.3. B. Braun Melsungen AG
15.3.4. Medtronic plc
15.3.5. 3M Company
15.3.6. Takeda Pharmaceutical Company Limited
15.3.7. Grifols, S.A.
15.3.8. CryoLife, Inc.
15.3.9. Integra LifeSciences Holdings Corporation
15.3.10. Terumo Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. TOPICAL HEMOSTAT MARKET MULTI-CURRENCY
FIGURE 2. TOPICAL HEMOSTAT MARKET MULTI-LANGUAGE
FIGURE 3. TOPICAL HEMOSTAT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CYANOACRYLATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FABRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY BYPASS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY VALVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY RESTORATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OPEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY MULTI-SPECIALTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY FIELD SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY TELE-SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY NATIONAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY INPATIENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY OUTPATIENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY INSTITUTIONAL WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY THIRD PARTY MARKETPLACES, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 108. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 110. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 112. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 113. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 114. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 115. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 116. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 118. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 119. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 121. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 123. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 124. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 125. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 126. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 128. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 130. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 131. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 132. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 133. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 134. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 136. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 138. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 141. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 143. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 217. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 219. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 221. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 222. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 223. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 224. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 225. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 227. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 228. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 230. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 232. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 233. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 234. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 235. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 237. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 239. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 240. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 241. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 242. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 243. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 245. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 246. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 247. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 248. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 250. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 251. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 252. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 271. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 273. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 275. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 276. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 277. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 278. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 279. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 281. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 282. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 283. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 284. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 286. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 287. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 288. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 289. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 291. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 293. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 294. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 295. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 296. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 297. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 299. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 300. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 301. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 302. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 304. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 305. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 306. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 326. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, 2018-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 328. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY CARDIOVASCULAR SURGERY, 2018-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY DENTAL SURGERY, 2018-2030 (USD MILLION)
TABLE 330. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY GENERAL SURGERY, 2018-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY NEUROSURGERY, 2018-2030 (USD MILLION)
TABLE 332. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 334. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 336. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 337. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY SPECIALTY CENTERS, 2018-2030 (USD MILLION)
TABLE 338. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 339. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY DIRECT SALES, 2018-2030 (USD MILLION)
TABLE 340. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 342. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 343. SOUTH AFRICA TO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Topical Hemostat market report include:
  • Johnson & Johnson
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Medtronic plc
  • 3M Company
  • Takeda Pharmaceutical Company Limited
  • Grifols, S.A.
  • CryoLife, Inc.
  • Integra LifeSciences Holdings Corporation
  • Terumo Corporation

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.41 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.36 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Topical Hemostat Market Size, Share & Trends Analysis Report By Type (Thrombin, Collagen, Gelatin), By Application (General Surgery, Cardiovascular Surgery), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Topical Hemostat Market Size, Share & Trends Analysis Report By Type (Thrombin, Collagen, Gelatin), By Application (General Surgery, Cardiovascular Surgery), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 170 Pages
  • Global
From
Hemostats Market Report 2025 - Product Image

Hemostats Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - Product Image

Topical Absorbable Hemostats Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036

  • Report
  • Global
From
Hemostats and Tissue Sealants - Global Strategic Business Report - Product Image

Hemostats and Tissue Sealants - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Oxidized Regenerated Cellulose Based Hemostats Market by Product Type, Application, End User, Sales Channel - Global Forecast to 2030 - Product Image

Oxidized Regenerated Cellulose Based Hemostats Market by Product Type, Application, End User, Sales Channel - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From

About the Topical Hemostat Market

In the field of wound care, the Topical Hemostat market encompasses a range of products designed to promote hemostasis, which is the process of blood clot formation to stop bleeding. These products are particularly crucial in surgical procedures, trauma situations, and in treating individuals with clotting deficiencies. Topical hemostats are available in various forms, including granular powders, films, pads, and gels. They work by different mechanisms; some provide a physical barrier to bleeding, while others promote the aggregation of platelets or catalyze the clotting process through biological or synthetic materials. The choice of topical hemostat may depend on factors such as the nature and location of the wound, the extent of bleeding, and any underlying patient conditions. With ongoing research and development, the market has seen the introduction of more advanced hemostatic agents that offer improved efficacy, faster action, and greater biocompatibility. Several companies are prominent in the Topical Hemostat market, maintaining a strong presence in the wound care sector. Notable players include Johnson & Johnson (with its ETHICON subsidiary), Baxter International Inc., Becton, Dickinson and Company (BD), CryoLife Inc., Pfizer Inc., and Z-Medica, LLC. These companies engage in the development, manufacturing, and distribution of hemostatic products, and often invest in research to advance the field of topical hemostasis further. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.